Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer
Maria Semitekolou, View ORCID ProfileNikolaos Paschalidis, View ORCID ProfileDomenico Lo Tartaro, Aikaterini Tsitsopoulou, Panagiota Stamou, Alexandros Mavroudis, Effrosyni Markaki, Athina Varveri, Ioannis Morianos, Matthieu Lavigne, Charalampos Fotsitzoudis, Sophia Magkouta, Konstantina Dede, Ioannis Kalomenidis, Konstantinos Samitas, Konstantinos Potaris, View ORCID ProfileAndrea Cossarizza, Dimitrios Mavroudis, View ORCID ProfileSara De Biasi, View ORCID ProfilePanayiotis Verginis
doi: https://doi.org/10.1101/2024.08.27.24312529
Maria Semitekolou
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
2Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
3Dendritic cells and Adaptive Immunity Unit, Institut Pasteur, CNRS UMR3738 “Developmental biology and stem cells”, Institut Pasteur, Paris, France
Nikolaos Paschalidis
2Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
Domenico Lo Tartaro
4Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy
Aikaterini Tsitsopoulou
2Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
Panagiota Stamou
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
Alexandros Mavroudis
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
Effrosyni Markaki
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
Athina Varveri
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
Ioannis Morianos
5Host Defense & Fungal Pathogenesis Laboratory, Medical School, University of Crete, Heraklion, Greece
11Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Greece
Matthieu Lavigne
11Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Greece
Charalampos Fotsitzoudis
6Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.
Sophia Magkouta
7st, Greece
Konstantina Dede
7st, Greece
Ioannis Kalomenidis
7st, Greece
Konstantinos Samitas
8th, Athens, Greece
Konstantinos Potaris
9Department of Thoracic Surgery, Athens Chest Hospital ‘Sotiria’, Athens, Greece
Andrea Cossarizza
4Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy
10National Institute for Cardiovascular Research, Bologna, Italy
Dimitrios Mavroudis
6Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.
Sara De Biasi
4Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy
Panayiotis Verginis
1Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
11Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Greece
Article usage
Posted August 28, 2024.
Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer
Maria Semitekolou, Nikolaos Paschalidis, Domenico Lo Tartaro, Aikaterini Tsitsopoulou, Panagiota Stamou, Alexandros Mavroudis, Effrosyni Markaki, Athina Varveri, Ioannis Morianos, Matthieu Lavigne, Charalampos Fotsitzoudis, Sophia Magkouta, Konstantina Dede, Ioannis Kalomenidis, Konstantinos Samitas, Konstantinos Potaris, Andrea Cossarizza, Dimitrios Mavroudis, Sara De Biasi, Panayiotis Verginis
medRxiv 2024.08.27.24312529; doi: https://doi.org/10.1101/2024.08.27.24312529
Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer
Maria Semitekolou, Nikolaos Paschalidis, Domenico Lo Tartaro, Aikaterini Tsitsopoulou, Panagiota Stamou, Alexandros Mavroudis, Effrosyni Markaki, Athina Varveri, Ioannis Morianos, Matthieu Lavigne, Charalampos Fotsitzoudis, Sophia Magkouta, Konstantina Dede, Ioannis Kalomenidis, Konstantinos Samitas, Konstantinos Potaris, Andrea Cossarizza, Dimitrios Mavroudis, Sara De Biasi, Panayiotis Verginis
medRxiv 2024.08.27.24312529; doi: https://doi.org/10.1101/2024.08.27.24312529
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2838)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (713)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6768)
- Radiology and Imaging (1487)
- Respiratory Medicine (898)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (173)